Literature DB >> 10866689

A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts.

L Vitelli1, G Condorelli, V Lulli, T Hoang, L Luchetti, C M Croce, C Peschle.   

Abstract

Human proerythroblasts and early erythroblasts, generated in vitro by normal adult progenitors, contain a pentamer protein complex comprising the tal-1 transcription factor heterodimerized with the ubiquitous E2A protein and linked to Lmo2, Ldb1, and retinoblastoma protein (pRb). The pentamer can assemble on a consensus tal-1 binding site. In the pRb(-) SAOS-2 cell line transiently transfected with a reporter plasmid containing six tal-1 binding site, pRb enhances the transcriptional activity of tal-1-E12-Lmo2 and tal-1-E12-Lmo2-Ldb1 complexes but not that of a tal-1-E12 heterodimer. We explored the functional significance of the pentamer in erythropoiesis, specifically, its transcriptional effect on the c-kit receptor, a tal-1 target gene stimulating early hematopoietic proliferation downmodulated in erythroblasts. In TF1 cells, the pentamer decreased the activity of the reporter plasmid containing the c-kit proximal promoter with two inverted E box-2 type motifs. In SAOS-2 cells the pentamer negatively regulates (i) the activity of the reporter plasmid containing the proximal human c-kit promoter and (ii) endogenous c-kit expression. In both cases pRb significantly potentiates the inhibitory effect of the tal-1-E12-Lmo2-Ldb1 tetramer. These data indicate that this pentameric complex assembled in maturing erythroblasts plays an important regulatory role in c-kit downmodulation; hypothetically, the complex may regulate the expression of other critical erythroid genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866689      PMCID: PMC85982          DOI: 10.1128/MCB.20.14.5330-5342.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Chromatin immunoselection defines a TAL-1 target gene.

Authors:  S Cohen-Kaminsky; L Maouche-Chrétien; L Vitelli; M A Vinit; I Blanchard; M Yamamoto; C Peschle; P H Roméo
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 2.  c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.

Authors:  S D Lyman; S E Jacobsen
Journal:  Blood       Date:  1998-02-15       Impact factor: 22.113

3.  Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.

Authors:  R O Bash; S Hall; C F Timmons; W M Crist; M Amylon; R G Smith; R Baer
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

Review 4.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

5.  Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cells.

Authors:  M Z Ratajczak; D Perrotti; P Melotti; M Powzaniuk; B Calabretta; K Onodera; D A Kregenow; B Machalinski; A M Gewirtz
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

6.  Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.

Authors:  G Condorelli; L Vitelli; M Valtieri; I Marta; E Montesoro; V Lulli; R Baer; C Peschle
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

7.  Expression of TAL-1 proteins in human tissues.

Authors:  K Pulford; N Lecointe; K Leroy-Viard; M Jones; D Mathieu-Mahul; D Y Mason
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

8.  Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.

Authors:  C Labbaye; M Valtieri; T Barberi; E Meccia; B Masella; E Pelosi; G L Condorelli; U Testa; C Peschle
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.

Authors:  L Robb; I Lyons; R Li; L Hartley; F Köntgen; R P Harvey; D Metcalf; C G Begley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

10.  Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells.

Authors:  G Krosl; G He; M Lefrancois; F Charron; P H Roméo; P Jolicoeur; I R Kirsch; M Nemer; T Hoang
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more
  20 in total

1.  Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.

Authors:  Thorsten M Schlaeger; Anna Schuh; Simon Flitter; Andreas Fisher; Hanna Mikkola; Stuart H Orkin; Paresh Vyas; Catherine Porcher
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

2.  MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.

Authors:  Nadia Felli; Laura Fontana; Elvira Pelosi; Rosanna Botta; Desirée Bonci; Francesco Facchiano; Francesca Liuzzi; Valentina Lulli; Ornella Morsilli; Simona Santoro; Mauro Valtieri; George Adrian Calin; Chang-Gong Liu; Antonio Sorrentino; Carlo M Croce; Cesare Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

3.  Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene.

Authors:  Mark A Hall; Nicholas J Slater; C Glenn Begley; Jessica M Salmon; Leonie J Van Stekelenburg; Matthew P McCormack; Stephen M Jane; David J Curtis
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

4.  TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.

Authors:  Virginie Deleuze; Elias Chalhoub; Rawan El-Hajj; Christiane Dohet; Mikaël Le Clech; Pierre-Olivier Couraud; Philippe Huber; Danièle Mathieu
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

5.  Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex.

Authors:  Siavoush Dastmalchi; Lorna Wilkinson-White; Ann H Kwan; Roland Gamsjaeger; Joel P Mackay; Jacqueline M Matthews
Journal:  Protein Sci       Date:  2012-09-25       Impact factor: 6.725

6.  Erythropoietin modulation of podocalyxin and a proposed erythroblast niche.

Authors:  Pradeep Sathyanarayana; Madhu P Menon; Olga Bogacheva; Oleg Bogachev; Knut Niss; William S Kapelle; Estelle Houde; Jing Fang; Don M Wojchowski
Journal:  Blood       Date:  2007-04-02       Impact factor: 22.113

7.  MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis.

Authors:  Nadia Felli; Francesca Pedini; Paolo Romania; Mauro Biffoni; Ornella Morsilli; Germana Castelli; Simona Santoro; Simona Chicarella; Antonio Sorrentino; Cesare Peschle; Giovanna Marziali
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

8.  Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.

Authors:  Alex Appert; Chang-Hoon Nam; Natividad Lobato; Eva Priego; Ricardo Nunez Miguel; Tom Blundell; Lesley Drynan; Helen Sewell; Tomoyuki Tanaka; Terence Rabbitts
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

9.  Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors.

Authors:  L Vian; M Di Carlo; E Pelosi; F Fazi; S Santoro; A M Cerio; A Boe; V Rotilio; M Billi; S Racanicchi; U Testa; F Grignani; C Nervi
Journal:  Cell Death Differ       Date:  2013-10-18       Impact factor: 15.828

10.  Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase.

Authors:  Olivier Kosmider; Dorothée Buet; Isabelle Gallais; Nicole Denis; Françoise Moreau-Gachelin
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.